title: In vivo effect of single oral dose of artemether against early juvenile stages of Schistosoma mansoni Egyptian strain.
abstract: The current treatment and control of schistosomiasis, rely on a single drug, praziquantel, although, it has minor activity against juvenile stages of the parasite. Studies have shown that artemether (ART) exhibits effects against juveniles of Schistosoma mansoni Liberian and Puerto Rican strains, Schistosoma japonicum and Schistosoma haematobium. Aiming to assess the in vivo activity of single oral dose of ART against early juvenile stages of S. mansoni Egyptian strain, this study was established. Mice were treated with ART (400 mg/kg) at two time points evenly spaced over the period of larval development (7 and 21 days post-infection; pi), and a third treatment point (day 49 pi) was included to elucidate when susceptibility decreases. Administration of ART on day 7 pi reduced the total worm burden by 85.94%. The greatest reductions were seen when treatment was given on day 21 pi, with total and female worm burden reductions of 91.52% and 90.57%, respectively, and cessation of oviposition. Similar dose given on day 49 pi reduced total worm burden by 55.17% and female worm burden by 66.51%. Moreover, it induced significant reduction in the tissue egg load and significant alterations in the oogram pattern with decreased immature eggs and increased dead eggs. Antipathological activities were evident in significant reductions in granulomata count and diameter. In conclusion, ART exhibits major in vivo schistosomicidal effects against the early larval migratory stages of S. mansoni Egyptian strain, mainly the 21-day old schistosomula, hence preventing disease progression and morbidity.
authors.affiliation: Department of Parasitology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt. Electronic address: selbeshbishi@yahoo.com.
authors.forename: Samar N
authors.initials: SN
authors.lastname: El-Beshbishi
authors.forename: Amira
authors.initials: A
authors.lastname: Taman
authors.forename: Mohamed
authors.initials: M
authors.lastname: El-Malky
authors.forename: Manar S
authors.initials: MS
authors.lastname: Azab
authors.forename: Amira K
authors.initials: AK
authors.lastname: El-Hawary
authors.forename: Dina A
authors.initials: DA
authors.lastname: El-Tantawy
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000077549:Artemether; D037621:Artemisinins / Q000494:pharmacology*; D001700:Biomphalaria; D005260:Female; D008099:Liver / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D012550:Schistosoma mansoni / Q000187:drug effects* / Q000254:growth & development; D012555:Schistosomiasis mansoni / Q000188:drug therapy* / Q000473:pathology; D012556:Schistosomicides / Q000494:pharmacology*
chemical_list: D037621:Artemisinins; D012556:Schistosomicides; D000077549:Artemether
keywords: Artemether; Histopathological study; Juvenile stages; Schistosoma mansoni; Schistosomula; Worm burden